160 related articles for article (PubMed ID: 36851388)
1. Antitumor Effects of Esculetin, a Natural Coumarin Derivative, against Canine Mammary Gland Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
Choi J; Yoo MJ; Park SY; Seol JW
Vet Sci; 2023 Jan; 10(2):. PubMed ID: 36851388
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells.
Lee R; Lee WY; Park HJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732133
[TBL] [Abstract][Full Text] [Related]
3. In vitro anticancer effects of esculetin against human leukemia cell lines involves apoptotic cell death, autophagy, G0/G1 cell cycle arrest and modulation of Raf/MEK/ERK signalling pathway.
Wang X; Yang C; Zhang Q; Wang C; Zhou X; Zhang X; Liu S
J BUON; 2019; 24(4):1686-1691. PubMed ID: 31646826
[TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin Exerts Anti-Tumor Activity on Canine Mammary Tumor Cells via Tumor Cell Apoptosis Induction and Angiogenesis Inhibition.
Jang H; Choi J; Park JK; Won G; Seol JW
Animals (Basel); 2021 May; 11(6):. PubMed ID: 34071074
[TBL] [Abstract][Full Text] [Related]
5. Esculetin, a natural coumarin compound, evokes Ca(2+) movement and activation of Ca(2+)-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells.
Chang HT; Chou CT; Lin YS; Shieh P; Kuo DH; Jan CR; Liang WZ
Tumour Biol; 2016 Apr; 37(4):4665-78. PubMed ID: 26508031
[TBL] [Abstract][Full Text] [Related]
6. Antiovarian cancer mechanism of esculetin: inducing G0/G1 arrest and apoptosis via JAK2/STAT3 signalling pathway.
Yin W; Fu X; Chang W; Han L; Meng J; Cao A; Ren X; Fan Z; Zhou S
J Pharm Pharmacol; 2023 Jan; 75(1):87-97. PubMed ID: 36332079
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer effect of palmatine through inhibition of the PI3K/AKT pathway in canine mammary gland tumor CMT-U27 cells.
Yoo MJ; Choi J; Jang YJ; Park SY; Seol JW
BMC Vet Res; 2023 Oct; 19(1):223. PubMed ID: 37880653
[TBL] [Abstract][Full Text] [Related]
8. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.
Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U
J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118
[TBL] [Abstract][Full Text] [Related]
9. Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle.
Turkekul K; Colpan RD; Baykul T; Ozdemir MD; Erdogan S
J Cancer Prev; 2018 Mar; 23(1):10-17. PubMed ID: 29629344
[TBL] [Abstract][Full Text] [Related]
10. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells.
Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT
Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298
[TBL] [Abstract][Full Text] [Related]
11. Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation.
Zhang G; Xu Y; Zhou HF
Med Sci Monit; 2019 Oct; 25():7853-7863. PubMed ID: 31630150
[TBL] [Abstract][Full Text] [Related]
12. In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours.
Schoos A; Knab VM; Gabriel C; Tripolt S; Wagner DA; Bauder B; Url A; Fux DA
Vet Comp Oncol; 2019 Dec; 17(4):507-521. PubMed ID: 31207004
[TBL] [Abstract][Full Text] [Related]
13. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Serrano C; Guzmán S; Arias JI; Torres CG
BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950
[TBL] [Abstract][Full Text] [Related]
14. Esculetin has therapeutic potential via the proapoptotic signaling pathway in A253 human submandibular salivary gland tumor cells.
Park SB; Kwon Jung W; Rae Kim H; Yu HY; Hwan Kim Y; Kim J
Exp Ther Med; 2022 Aug; 24(2):533. PubMed ID: 35837055
[TBL] [Abstract][Full Text] [Related]
15. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
Bi YL; Min M; Shen W; Liu Y
Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
[TBL] [Abstract][Full Text] [Related]
16. Effects of Tyrosine Kinase Inhibitor-masitinib Mesylate on Canine Mammary Tumour Cell Lines.
Ustun-Alkan F; Bakırel T; Üstüner O; Anlas C; Cinar S; Yıldırım F; Gürel A
J Vet Res; 2021 Sep; 65(3):351-359. PubMed ID: 34917849
[TBL] [Abstract][Full Text] [Related]
17. Esculetin inhibits proliferation, migration, and invasion of clear cell renal cell carcinoma cells.
Duan J; Shi J; Ma X; Xuan Y; Li P; Wang H; Fan Y; Gong H; Wang L; Pang Y; Pang S; Yan Y
Biomed Pharmacother; 2020 May; 125():110031. PubMed ID: 32164951
[TBL] [Abstract][Full Text] [Related]
18. Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells.
Kok SH; Yeh CC; Chen ML; Kuo MY
Oral Oncol; 2009 Dec; 45(12):1067-72. PubMed ID: 19720557
[TBL] [Abstract][Full Text] [Related]
19. Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway.
Wang J; Lu ML; Dai HL; Zhang SP; Wang HX; Wei N
Braz J Med Biol Res; 2015 Mar; 48(3):245-53. PubMed ID: 25517918
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells.
Kimura Y; Sumiyoshi M
Eur J Pharmacol; 2015 Jan; 746():115-25. PubMed ID: 25445053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
